Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)—An open-label, phase I/II study
- Ivetta Danylesko
- , Avichai Shimoni
- , Abraham Avigdor
- , Meirav Kedmi
- , Irina Amitai
- , Noga Shem-Tov
- , Ronit Yerushalmi
- , Borje S. Andersson
- , Arnon Nagler
Research output: Contribution to journal › Article › peer-review